Shenzhen Lions King Hi-Tech Co.,Ltd

Shenzhen Lions King Hi-Tech Co., Ltd. is a biotechnology enterprise founded in 2001 and listed on the ChiNext board of the Shenzhen Stock Exchange in 2023. The company is recognized as a leading player in China's biotechnology resource utilization sector and has been designated as a national high-tech enterprise. It is also noted for its innovative contributions, being listed among the "Top 70 Innovative Enterprises in Shenzhen" alongside prominent companies such as Huawei and Tencent. Lions King Hi-Tech operates primarily in two business segments: synthetic biology manufacturing and biomass resource recycling. The synthetic biology division, managed under the Longjian Biology brand, focuses on producing human milk oligosaccharides (HMOs) using advanced synthetic biology technologies. In biomass resource recycling, the company employs microbial and biocatalytic methods to convert waste into biodiesel and clean power, holding the largest market share in first-tier cities across China. The company has established over 30 recycling centers and is recognized for its pioneering efforts in large-scale biodiesel production.

Lions King Hi-Tech (301305.SZ) is a biotechnology enterprise, a leading player in China's biotechnology resource utilization industry, and a national high-tech enterprise. It is listed alongside Huawei and DJI as one of the "Top 70 Innovative Enterprises in Shenzhen". 1. Strengths and Position in Biomass Resource Recycling From 2017 to 2023, leveraging advanced microbial and genetic technologies, the company was consecutively recognized as a leading enterprise in biomass waste resource utilization by the E20 platform for seven years. As of May 2024, it has invested in, constructed, and operated 34 biomass resource recycling centers, holding the No. 1 market share in first-tier cities nationwide. Its total processing capacity ranks among the top in China, with 5 projects achieving a daily processing scale of over 1,000 tons. 2. Strengths and Position in Synthetic Biology Manufacturing Since 2023, multiple synthetic biology technologies of the company have passed the approval of the Ministry of Agriculture and Rural Affairs and the National Health Commission. It took the lead in China to achieve pilot-scale amplification of LNT (Lacto-N-tetraose) and LNnT (Lacto-N-neotetraose) in HMOs (Human Milk Oligosaccharides), with industry-leading fermentation concentration and purity of its products. As a result, the Zhuhai Human Milk Oligosaccharide Project of Lions King Group has become the first project in China to achieve industrial production of tetraose and neotetraose. 3. Strengths and Position in Bioenergy Lions King Hi-Tech is the first enterprise in China to adopt biocatalytic methods for large-scale production of biodiesel. In 2024, its Guangzhou project, backed by technical expertise in biocatalytic preparation of bioenergy, was listed as one of the first batch of bio-marine fuel refueling pilots announced by the National Energy Administration.